Kim, Grace J <br/><br/>
The Benefit of Chemotherapy in Esophageal Cancer Patients With Residual Disease After Trimodality Therapy.  [electronic resource] 

 -  American journal of clinical oncology  Apr 2016 
 - 136-41 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1537-453X 
<br/><br/><label>Standard No.: </label>10.1097/COC.0000000000000036  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--mortality<br/>Adult<br/>Carcinoma, Squamous Cell--mortality<br/>Chemoradiotherapy--methods<br/>Chemotherapy, Adjuvant--adverse effects<br/>Cisplatin--administration & dosage<br/>Docetaxel<br/>Esophageal Neoplasms--mortality<br/>Esophagectomy<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Neoplasm, Residual--drug therapy<br/>Proportional Hazards Models<br/>Retrospective Studies<br/>Taxoids--administration & dosage